Madison, Wis. | Live Webcast | Boston | Indianapolis Seattle | Louisville, Ky. | Pittsburgh
The Society for Immunotherapy of Cancer’s new online activity explains cancer immunotherapy and the immune system to patients.
SITC Cancer Immunotherapy Guidelines – Non-Small Cell Lung Cancer Webinar
Discuss NSCLC immunotherapy treatment guidelines in a free webinar on Sept. 13 at 1 p.m. EDT.
Attend the the 33rd Annual Meeting & Pre-Conference Programs this Nov. 7–11, 2018 at the Walter E. Washington Convention Center in Washington, D.C.
The Journal for ImmunoTherapy of Cancer (JITC) received its first impact factor of 8.374! JITC’s impact factor ranks in the top 8 percent of all journals published in the categories of oncology and immunology.
See members discuss the benefits of a SITC membership in this new video.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
We are currently organizing the 8 th InterAmerican Oncology Conference, "Current Status and Future of Anti-Cancer Therapies" will take place on October 17 th and 18 th , 2019 in Buenos Aires, Argentina.
Dres. Alex Adjei (Mayo Clinic, USA), Román ...
Usage of CRISPR/Cris9, an RNA guided DNA gene editing technology has powerful manipulative abilities. It has a special place in genetic engineering in its development. There is current development of this technology for therapeutic applications, particularly ...
Hi all- Fight Colorectal Cancer (CRC) will be hosting a webinar next Wednesday August 8th at 1:30p EST around biomarkers such as BRAF and HER2, as well as sidedness and what these mean for tailoring treatment for colorectal cancer patients. Be sure ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com